99 related articles for article (PubMed ID: 12593670)
21. IL-6 in inflammation, autoimmunity and cancer.
Hirano T
Int Immunol; 2021 Mar; 33(3):127-148. PubMed ID: 33337480
[TBL] [Abstract][Full Text] [Related]
22. SHP-2 in Lymphocytes' Cytokine and Inhibitory Receptor Signaling.
Niogret C; Birchmeier W; Guarda G
Front Immunol; 2019; 10():2468. PubMed ID: 31708921
[TBL] [Abstract][Full Text] [Related]
23. Sunitinib promotes myogenic regeneration and mitigates disease progression in the mdx mouse model of Duchenne muscular dystrophy.
Fontelonga TM; Jordan B; Nunes AM; Barraza-Flores P; Bolden N; Wuebbles RD; Griner LM; Hu X; Ferrer M; Marugan J; Southall N; Burkin DJ
Hum Mol Genet; 2019 Jul; 28(13):2120-2132. PubMed ID: 30806670
[TBL] [Abstract][Full Text] [Related]
24. The molecular details of cytokine signaling via the JAK/STAT pathway.
Morris R; Kershaw NJ; Babon JJ
Protein Sci; 2018 Dec; 27(12):1984-2009. PubMed ID: 30267440
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of IL-6 family cytokines by SOCS3.
Babon JJ; Varghese LN; Nicola NA
Semin Immunol; 2014 Feb; 26(1):13-9. PubMed ID: 24418198
[TBL] [Abstract][Full Text] [Related]
26. The biology and mechanism of action of suppressor of cytokine signaling 3.
Babon JJ; Nicola NA
Growth Factors; 2012 Aug; 30(4):207-19. PubMed ID: 22574771
[TBL] [Abstract][Full Text] [Related]
27. Leptin signaling: A key pathway in immune responses.
Procaccini C; Lourenco EV; Matarese G; La Cava A
Curr Signal Transduct Ther; 2009 Jan; 4(1):22-30. PubMed ID: 19774101
[TBL] [Abstract][Full Text] [Related]
28. Intracellular signalling pathways activated by leptin.
Frühbeck G
Biochem J; 2006 Jan; 393(Pt 1):7-20. PubMed ID: 16336196
[TBL] [Abstract][Full Text] [Related]
29. SOCS2 negatively regulates growth hormone action in vitro and in vivo.
Greenhalgh CJ; Rico-Bautista E; Lorentzon M; Thaus AL; Morgan PO; Willson TA; Zervoudakis P; Metcalf D; Street I; Nicola NA; Nash AD; Fabri LJ; Norstedt G; Ohlsson C; Flores-Morales A; Alexander WS; Hilton DJ
J Clin Invest; 2005 Feb; 115(2):397-406. PubMed ID: 15690087
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.
Heinrich PC; Behrmann I; Müller-Newen G; Schaper F; Graeve L
Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):297-314. PubMed ID: 9716487
[TBL] [Abstract][Full Text] [Related]
31. Joint disease caused by defective gp130-mediated STAT signaling.
Naka T; Kishimoto T
Arthritis Res; 2002; 4(3):154-6. PubMed ID: 12010564
[TBL] [Abstract][Full Text] [Related]
32. Negative regulation of gp130 signalling mediated through tyrosine-757 is not dependent on the recruitment of SHP2.
Fairlie WD; De Souza D; Nicola NA; Baca M
Biochem J; 2003 Jun; 372(Pt 2):495-502. PubMed ID: 12593670
[TBL] [Abstract][Full Text] [Related]
33. SHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130.
Lehmann U; Schmitz J; Weissenbach M; Sobota RM; Hortner M; Friederichs K; Behrmann I; Tsiaris W; Sasaki A; Schneider-Mergener J; Yoshimura A; Neel BG; Heinrich PC; Schaper F
J Biol Chem; 2003 Jan; 278(1):661-71. PubMed ID: 12403768
[TBL] [Abstract][Full Text] [Related]
34. SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130.
Schmitz J; Weissenbach M; Haan S; Heinrich PC; Schaper F
J Biol Chem; 2000 Apr; 275(17):12848-56. PubMed ID: 10777583
[TBL] [Abstract][Full Text] [Related]
35. TNF-alpha induces tyrosine phosphorylation and recruitment of the Src homology protein-tyrosine phosphatase 2 to the gp130 signal-transducing subunit of the IL-6 receptor complex.
Bode JG; Schweigart J; Kehrmann J; Ehlting C; Schaper F; Heinrich PC; Häussinger D
J Immunol; 2003 Jul; 171(1):257-66. PubMed ID: 12817006
[TBL] [Abstract][Full Text] [Related]
36. Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation.
Anhuf D; Weissenbach M; Schmitz J; Sobota R; Hermanns HM; Radtke S; Linnemann S; Behrmann I; Heinrich PC; Schaper F
J Immunol; 2000 Sep; 165(5):2535-43. PubMed ID: 10946280
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]